Securities Suit V. Axonyx Over Alzheimer's Drug Nixed
A federal judge has dismissed a securities suit brought against Axonyx Inc. over the pharmaceutical company's alleged misstatements surrounding the development of an experimental Alzheimer's disease treatment....To view the full article, register now.
Already a subscriber? Click here to view full article